BGLC vs FAST · rev $9.5M vs P/E 43, rev $7.55B
BioNexus Gene Lab Corp Common stock (BGLC) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
BGLC currently screens at market cap $6.1M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the BGLC and FAST stock pages for the full models.
Not investment advice.